Company / Dividends Paid
Abbott Laboratories Dividends Paid History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Dividends Paid
$4.1B
FY2025
5-year range
$2.3B / $4.1B
FY2021-FY2025
Trend
+7.3%
vs FY2024
Sector context
#1 of 46
Health Care
What the data says
Among 46 Health Care companies, Abbott Laboratories is in the top 2% for dividends paid. Dividends Paid has increased for 5 consecutive years, from $2.0B in FY2020 to $4.1B in FY2025.
Based on SEC 10-K filings.
$4.1B in FY2025 with a 5-year CAGR of +15.8%. Ranks 1st among 46 companies in Health Care.
Improved from $3.2B to $4.1B over the past 2 years.
Health Care sector context is included.
Dividends Paid over time
Growth rates
- 3-Year CAGR
- +17.2%
- 5-Year CAGR
- +15.8%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 46This company $4.1B Sector average $493.2M
▼
+734.6% above sector average
Key checks
Key Insights
- Abbott Laboratories's dividends paid has grown for 5 consecutive years.
- 5-year CAGR of +15.8%, indicating consistent growth.
- In FY2025, dividends paid increased 7.3% year-over-year.
- Ranks #1 out of 46 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 31.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 27.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Dividends PaidValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.1B | +7.3% |
| FY2024 | $3.8B | +19.8% |
| FY2023 | $3.2B | +25.1% |
| FY2022 | $2.6B | +12.8% |
| FY2021 | $2.3B | +15.0% |
| FY2020 | $2.0B | -13.0% |
| FY2019 | $2.3B | +47.5% |
| FY2018 | $1.5B | +6.7% |
| FY2017 | $1.4B | +7.5% |
| FY2016 | $1.3B | +52.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026